Literature DB >> 439926

Comparative study of prophylactic antibiotics in cardiac surgery. Clindamycin versus cephalothin.

F D Pien, N L Michael, R Mamiya, H Takaki, S Slavish, A Bruce, R J Moreno-Cabral.   

Abstract

A randomized, prospective study of the relative effectiveness of clindamycin versus cephalothin was performed in 263 adult patients having cardiac surgery from September, 1977, to August, 1978. There were no statistically significant differences in frequency of postoperative infections in these two antibiotic groups. Wound infection developed in 6.5 percent of the cephalothin group and 3.2 percent of the clindamycin group. Urinary tract infection developed in 5.6 percent of the clindamycin group and 2.1 percent of the cephalothin group. Four bacteremic episodes occurred in the clindamycin-treated patients, and one episode of bacteremia occurred in a cephalothin-treated patient. No cases of endocarditis occurred during the study. Clindamycin deserved consideration as an alternative prophylactic agent to cephalothin for cardiac surgery.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 439926

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  Perioperative antibiotic prophylaxis in cardiovascular surgery: a prospective randomized comparative trial of cefazolin versus ceftriaxone.

Authors:  M Soteriou; F Recker; S Geroulanos; M Turina
Journal:  World J Surg       Date:  1989 Nov-Dec       Impact factor: 3.352

2.  Current indications for the use of clindamycin: A critical review.

Authors:  M Smieja
Journal:  Can J Infect Dis       Date:  1998-01

3.  A clinical study of postoperative infections following open-heart surgery: occurrence and microbiological findings in 782 cases.

Authors:  H Orita; T Shimanuki; M Fukasawa; K Inui; S Goto; M Washio; H Horikawa
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

4.  Comparison of cephalothin and ceforanide prophylaxis in cardiac surgery with cardiopulmonary bypass.

Authors:  W Karney; R Correa-Coronas; R Zajtchuk; J Schwartz; L P Smith; E Tramont
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.